Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83K Hold
684
﹤0.01% 3660
2026
Q1
$2.47K Buy
+684
New +$2.37K ﹤0.01% 3595
2025
Q4
Sell
-1,248
Closed -$8.47K 4111
2025
Q3
$8.47K Sell
1,248
-88
-7% -$727 ﹤0.01% 2958
2025
Q2
$18.2K Buy
1,336
+150
+13% +$1.42K ﹤0.01% 2508
2025
Q1
$6.45K Buy
+1,186
New +$6.73K ﹤0.01% 2966

Other funds holding LFMD

GAMMA Investing's LFMD Position: Q2 2026 in Review

GAMMA Investing held its LifeMD (LFMD) position steady in Q2 2026 at 684 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

GAMMA Investing first reported a position in LFMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $18.2K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • GAMMA Investing held 684 shares of LifeMD worth $2.83K as of Q2 2026.
  • GAMMA Investing left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3660 holding.
  • GAMMA Investing first reported a position in LifeMD in Q1 2025 and has held it in 5 quarters since.
  • GAMMA Investing's LifeMD position peaked at $18.2K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.